Premium
CD27 STIMULATION ENHANCES CD20 MAB THERAPY THROUGH ACTIVATION OF INNATE IMMUNITY
Author(s) -
Turaj A.H.,
RoseZerilli M.,
Cox K.,
James S.,
AlShamkhani A.,
Keler T.,
Johnson P.W.,
Thirdborough S.M.,
Beers S.A.,
Glennie M.J.,
Cragg M.S.,
Lim S.H.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2437_123
Subject(s) - monoclonal antibody , immunology , tlr3 , cancer research , cytokine , biology , t cell , cd8 , myeloid , innate immune system , antibody , immune system , toll like receptor